Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion type Assertion NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_head.
- NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion description "[Patients with moderate/strong tumor FERMT1 protein expression (n = 122) showed significantly poorer overall survival (OS; P = 0.011) and disease-free survival (DFS; P = 0.005) than patients with negative/weak tumor FERMT1 protein expression (n = 81).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_provenance.
- NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion evidence source_evidence_literature NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_provenance.
- NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion SIO_000772 21220475 NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_provenance.
- NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion wasDerivedFrom befree-20150227 NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_provenance.
- NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_assertion wasGeneratedBy ECO_0000203 NP919447.RAKthHwf_4SPyo9Qr5mNndmBa9lIxgX8N7MQrdfPNWdBQ130_provenance.